Ticari markalar

BARACLUDE^® (entekavir) – Bristol-Myers Squibb Company

OPDIVO^® (nivolumab) – Bristol-Myers Squibb Company

ORENCIA^® (abatasept) – Bristol-Myers Squibb Company

SPRYCEL^® (dasatinib) – Bristol-Myers Squibb Company

YERVOY^® (ipilimumab) – Bristol-Myers Squibb Company

NO-TR-2100044 – 10/2021